By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Daan Gene Co., Ltd.

Daan Gene Co., Ltd. (002030.SZ)

SHZ Currency in CNY
¥6.75
+¥0.01
+0.15%
Last Update: 29 Aug 2025, 07:04
¥9.26B
Market Cap
-21.14
P/E Ratio (TTM)
Forward Dividend Yield
¥4.92 - ¥7.77
52 Week Range

002030.SZ Stock Price Chart

Explore Daan Gene Co., Ltd. interactive price chart. Choose custom timeframes to analyze 002030.SZ price movements and trends.

002030.SZ Company Profile

Discover essential business fundamentals and corporate details for Daan Gene Co., Ltd. (002030.SZ) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

9 Aug 2004

Employees

1.97K

CEO

Luo Huang

Description

Daan Gene Co., Ltd. researches and develops, manufactures, and sells clinical test reagents and instruments. The company offers fluorescence quantitative PCR products, time resolution series products, enzyme-linked immunoassay products, instrument products, and scientific research service products. It also provides medical examination, and health consultation and management services, such as genetic susceptibility gene testing, tumor marker testing, cervical cancer screening, routine physical examination, and other health services. The company was formerly known as Da An Gene Co., Ltd. of Sun Yat-Sen University. The company was founded in 2001 and is headquartered in Guangzhou, the People's Republic of China.

002030.SZ Financial Timeline

Browse a chronological timeline of Daan Gene Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 29 Apr 2025

EPS came in at ¥0.04 , while revenue for the quarter reached ¥169.14M .

Earnings released on 28 Mar 2025

EPS came in at -¥0.30 , while revenue for the quarter reached ¥261.97M .

Earnings released on 30 Oct 2024

EPS came in at -¥0.07 , while revenue for the quarter reached ¥189.24M .

Earnings released on 30 Aug 2024

EPS came in at -¥0.03 , while revenue for the quarter reached ¥200.51M .

Dividend declared on 14 Jun 2024

A dividend of ¥0.02 per share was announced, adjusted to ¥0.02. The dividend was paid on 14 Jun 2024.

Earnings released on 29 Apr 2024

EPS came in at -¥0.26 , while revenue for the quarter reached ¥197.08M .

Earnings released on 29 Mar 2024

EPS came in at -¥0.18 , while revenue for the quarter reached ¥333.38M .

Earnings released on 30 Oct 2023

EPS came in at -¥0.04 , while revenue for the quarter reached ¥306.12M .

Earnings released on 30 Aug 2023

EPS came in at ¥0.26 , while revenue for the quarter reached ¥195.18M .

Dividend declared on 13 Jun 2023

A dividend of ¥1.75 per share was announced, adjusted to ¥1.75. The dividend was paid on 13 Jun 2023.

Earnings released on 28 Apr 2023

EPS came in at ¥0.36 , while revenue for the quarter reached ¥2.71B .

Earnings released on 31 Mar 2023

EPS came in at ¥0.03 , while revenue for the quarter reached ¥341.04M .

Earnings released on 30 Sept 2022

EPS came in at ¥0.94 , while revenue for the quarter reached ¥2.66B .

Earnings released on 30 Jun 2022

EPS came in at ¥1.36 , while revenue for the quarter reached ¥3.31B .

Dividend declared on 9 May 2022

A dividend of ¥1.11 per share was announced, adjusted to ¥1.11. The dividend was paid on 9 May 2022.

Earnings released on 29 Apr 2022

EPS came in at ¥1.20 , while revenue for the quarter reached ¥3.36B .

Earnings released on 31 Dec 2021

EPS came in at ¥0.78 , while revenue for the quarter reached ¥2.03B .

Earnings released on 1 Nov 2021

EPS came in at ¥0.33 , while revenue for the quarter reached ¥1.14B .

Earnings released on 30 Sept 2021

EPS came in at ¥0.66 , while revenue for the quarter reached ¥2.15B .

Dividend declared on 19 May 2021

A dividend of ¥0.55 per share was announced, adjusted to ¥0.34. The dividend was paid on 19 May 2021.

Stock split effective on 19 May 2021

Shares were split 8 : 5 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 31 Mar 2021

EPS came in at ¥0.80 , while revenue for the quarter reached ¥2.34B .

Earnings released on 31 Dec 2020

EPS came in at ¥0.65 , while revenue for the quarter reached ¥1.78B .

Earnings released on 30 Sept 2020

EPS came in at ¥0.54 , while revenue for the quarter reached ¥1.43B .

002030.SZ Stock Performance

Access detailed 002030.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run